Jonathan E Lim
Chairman & CEO, Director, 10% owner at Erasca, Inc. (ERAS)
Jonathan E Lim has filed 20 insider reports with the SEC since February 2022, as director at Boundless Bio, Inc. (BOLD), director at Maze Therapeutics, Inc. (MAZE) and chairman & CEO, director and 10% owner at Erasca, Inc. (ERAS). Jonathan E Lim made no open-market purchases or sales in the last 12 months. The latest filing, on June 15, 2026, reports grant or award at Boundless Bio, Inc. (BOLD).
- Filings
- 20
- Companies
- 3
- Bought on market
- $4.71M
- Sold on market
- None
Companies where Jonathan E Lim is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| BOLD Boundless Bio, Inc. | Director | $2.46 | Jun 15, 2026 | ||||
| MAZE Maze Therapeutics, Inc. | Director | 20,744 | $34.19 | Jun 10, 2026 | |||
| ERAS Erasca, Inc. | Chairman & CEO, Director, 10% owner | $4.71M | $2.05 | $14.41+603% | Jan 30, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 15, 2026BOLDSEC Form 4 filed by Director Lim Jonathan EForm 4Grant or award
- Jun 8, 2026MAZESEC Form 4 filed by Director Lim Jonathan EForm 4Grant or award
- Jan 29, 2026ERASSEC Form 4 filed by Chairman & CEO Lim Jonathan EForm 4Grant or award
- Sep 22, 2025MAZESEC Form 4 filed by Director Lim Jonathan EForm 4Grant or award
- Jun 23, 2025BOLDSEC Form 4 filed by Director Lim Jonathan EForm 4Grant or award
- Feb 3, 2025ERASSEC Form 4 filed by Chairman & CEO Lim Jonathan EForm 4Grant or award
- Feb 3, 2025MAZEDirector Lim Jonathan E converted options into 307,956 sharesForm 4Grant or awardConversion of a derivativeSale back to the company
- Jun 20, 2024ERASSEC Form 4 filed by Chairman & CEO Lim Jonathan EForm 4Grant or award
- Jun 20, 2024BOLDSEC Form 4 filed by Director Lim Jonathan EForm 4Grant or award
- Feb 5, 2024ERASSEC Form 4 filed by Lim Jonathan EForm 4Grant or award
- Dec 6, 2023+$1.7MERASLim Jonathan E bought $1,696,179 worth of shares (1,000,000 units at $1.70)Form 4/AOpen-market purchase
- Oct 5, 2023+$2.03MERASLim Jonathan E bought $2,026,000 worth of shares (1,000,000 units at $2.03)Form 4/AOpen-market purchase
- Jun 26, 2023ERASSEC Form 4 filed by Lim Jonathan E (Amendment)Form 4
- Jun 8, 2023+$275KERASSEC Form 4 filed by Lim Jonathan EForm 4Open-market purchase
- Mar 28, 2023+$284KERASSEC Form 4 filed by Lim Jonathan EForm 4Open-market purchase
- Nov 30, 2022ERASSEC Form 5: Lim Jonathan E gifted 2,000,006 sharesForm 5Gift
- Feb 1, 2023ERASSEC Form 4 filed by Lim Jonathan EForm 4Grant or award
- Jan 10, 2023+$231KERASSEC Form 4: Lim Jonathan E bought $231,420 worth of shares (60,000 units at $3.86)Form 4Open-market purchase
- Dec 14, 2022+$200KERASSEC Form 4: Lim Jonathan E bought $199,600 worth of shares (40,000 units at $4.99)Form 4Open-market purchase
- Feb 1, 2022ERASSEC Form 4 filed by Lim Jonathan EForm 4Grant or award
Compare Jonathan E Lim with
- Jonathan E Lim vs Kevin Tang1 shared
- Jonathan E Lim vs Jason V Coloma1 shared
- Jonathan E Lim vs Harold Bernstein1 shared
- Jonathan E Lim vs Atul Dandekar1 shared
- Jonathan E Lim vs Phillips Courtney1 shared
- Jonathan E Lim vs Sophie Kornowski1 shared
Other insiders at the same companies
- Kevin TangBOLD
- Jason V ColomaMAZE
- Harold BernsteinMAZE
- Atul DandekarMAZE
- Phillips CourtneyMAZE
- Sophie KornowskiMAZE
- Paula A JohnsonMAZE
- Erasca FoundationERAS
- Charles S. FuchsERAS
- Keith CrandellBOLD
- ARCH Venture Fund IX, L.P.BOLD
- Start Valerie Denise HardingERAS
- Jean I LiuERAS
- Pratik S MultaniERAS
- Alexander W. CasdinERAS
- Julie HambletonERAS
Questions about Jonathan E Lim
- What is Jonathan E Lim's role at Erasca, Inc.?
- Jonathan E Lim reports to the SEC as chairman & CEO, director and 10% owner at Erasca, Inc. (ERAS), according to the latest filing on January 30, 2026. Jonathan E Lim has also filed as director at Boundless Bio, Inc. (BOLD) and director at Maze Therapeutics, Inc. (MAZE).
- How many shares does Jonathan E Lim own?
- After the latest filing that states it, Jonathan E Lim directly owned 20,744 shares of Maze Therapeutics, Inc. (MAZE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jonathan E Lim bought or sold stock recently?
- The most recent open-market purchase was on December 6, 2023: bought 1,000,000 shares of Erasca, Inc. (ERAS) for $1.7M at an average of $1.70.
- How do I get alerts when Jonathan E Lim files?
- Follow Jonathan E Lim on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jonathan E Lim (SEC CIK 0001283290). Totals count each trade once, skipping amendments whose original is on file, from Feb 4, 2022 on. View on SEC EDGAR